Viewing Study NCT00945269


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-27 @ 8:14 AM
Study NCT ID: NCT00945269
Status: TERMINATED
Last Update Posted: 2022-11-15
First Post: 2009-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma
Sponsor: Fred Hutchinson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module